Carregant...
Improved prognosis in gastric adenocarcinoma among metformin users in a population-based study
BACKGROUND: Metformin may improve the prognosis in gastric adenocarcinoma, but the existing literature is limited and contradictory. METHODS: This was a Swedish population-based cohort study of diabetes patients who were diagnosed with gastric adenocarcinoma in 2005–2018 and followed up until Decemb...
Guardat en:
| Publicat a: | Br J Cancer |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Nature Publishing Group UK
2021
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8292480/ https://ncbi.nlm.nih.gov/pubmed/33972744 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41416-021-01408-8 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|